RBFC
BEAT

Roman Butler Fullerton & Co’s BioTelemetry, Inc. BEAT Stock Holding History

Roman Butler Fullerton & Co’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,485
Closed -$704K – 188
2018
Q4 		$704K Buy
+10,485
New +$630K 0.6% 60

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Roman Butler Fullerton & Co's BEAT Position: Q1 2019 in Review

Roman Butler Fullerton & Co sold out of BioTelemetry, Inc. (BEAT) in Q1 2019, closing a stake of 10,485 shares — an estimated $704K sold.

Roman Butler Fullerton & Co first reported a position in BEAT in Q4 2018 and held it in 1 quarter. The position peaked at $704K in Q4 2018. 311 funds tracked by Wall St. Rank hold BEAT as of Q1 2019.

  • Roman Butler Fullerton & Co reported no remaining BioTelemetry, Inc. position as of Q1 2019 after selling out during the quarter.
  • Roman Butler Fullerton & Co sold 10,485 BioTelemetry, Inc. shares in Q1 2019, an estimated $704K.
  • Roman Butler Fullerton & Co first reported a position in BioTelemetry, Inc. in Q4 2018 and held it in 1 quarter.
  • Roman Butler Fullerton & Co's BioTelemetry, Inc. position peaked at $704K in Q4 2018.
  • 311 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2019.

Based on Roman Butler Fullerton & Co's 13F filing for Q1 2019, filed 24 Apr 2019.